PEDIA-DOSE Trademark

Trademark Overview


On Tuesday, January 31, 2012, a trademark application was filed for PEDIA-DOSE with the United States Patent and Trademark Office. The USPTO has given the PEDIA-DOSE trademark a serial number of 85530278. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, May 26, 2023. This trademark is owned by Asepsis Pharmaceuticals Inc.. The PEDIA-DOSE trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; Antibacterial pharmaceuticals; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of pediatric otitis, external otic inflammation, conjunctivitis, keratitis, rhinitis, allergy, nausea, diarrhea, croup, malaise, cough, cold, upset stomach, fever, gas, acidity, constipation, itching, dermatitis, jaundice, mumps, and acne; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations...
pedia-dose

General Information


Serial Number85530278
Word MarkPEDIA-DOSE
Filing DateTuesday, January 31, 2012
Status710 - CANCELLED - SECTION 8
Status DateFriday, May 26, 2023
Registration Number4243572
Registration DateTuesday, November 13, 2012
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 15, 2012

Trademark Statements


Goods and ServicesAnti-infectives; Antibacterial pharmaceuticals; Antiemetics; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Homeopathic pharmaceuticals for use in the treatment of pediatric otitis, external otic inflammation, conjunctivitis, keratitis, rhinitis, allergy, nausea, diarrhea, croup, malaise, cough, cold, upset stomach, fever, gas, acidity, constipation, itching, dermatitis, jaundice, mumps, and acne; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Intravenous fluids used for rehydration, nutrition and the delivery of pharmaceutical preparations; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the treatment and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for wounds; Pharmaceutical products for ophthalmological use; Pharmaceuticals, namely, anti-infectives; Potassium preparations for pharmaceutical purposes

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, May 26, 2023
Primary Code005
First Use Anywhere DateTuesday, January 31, 2012
First Use In Commerce DateTuesday, January 31, 2012

Trademark Owner History


Party NameAsepsis Pharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSarasota, FL 34234

Party NameAsepsis Pharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSarasota, FL 34234

Party NameAsepsis Pharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSarasota, FL 34234

Trademark Events


Event DateEvent Description
Friday, May 26, 2023CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Saturday, November 13, 2021COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, October 30, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Tuesday, October 30, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Tuesday, October 30, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, October 26, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, October 26, 2018TEAS SECTION 8 RECEIVED
Monday, April 30, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 13, 2017COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 13, 2012REGISTERED-PRINCIPAL REGISTER
Friday, October 12, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, October 11, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, October 9, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, October 2, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, October 1, 2012USE AMENDMENT FILED
Tuesday, October 2, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 1, 2012TEAS STATEMENT OF USE RECEIVED
Tuesday, July 10, 2012NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 15, 2012OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 15, 2012PUBLISHED FOR OPPOSITION
Wednesday, April 25, 2012NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 10, 2012LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, April 9, 2012ASSIGNED TO LIE
Monday, March 19, 2012APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 17, 2012ASSIGNED TO EXAMINER
Monday, February 6, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 3, 2012NEW APPLICATION ENTERED